Market Research Life Sciences Market Research Pharmaceuticals Market Research Prescription Drugs Market Research

Pharmaceuticals in Australia - Market Summary, Competitive Analysis and Forecast, 2016-2025

Best Price Guarantee Length Publisher Published Date SKU
from $350 48 Pages MarketLine July, 2021 MTLN17015423
Best Price Guarantee
Price from $350
Length 48 Pages
Publisher MarketLine
Published Date July, 2021
SKU MTLN17015423

Pharmaceuticals in Australia - Market Summary, Competitive Analysis and Forecast, 2016-2025

Summary

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Australian pharmaceuticals market had total revenues of $12.4bn in 2020, representing a compound annual growth rate (CAGR) of 2.4% between 2016 and 2020.
  • Australia’s population is aging, with being 21-23% of the population estimated to be aged 65 and over by 2066. Chronic diseases are also becoming increasingly common, and overall, this will continue to drive the demand for pharmaceuticals in the country.
  • Australia’s domestic pharmaceutical manufacturing capacity is likely to be boosted by the introduction of the Modern Manufacturing Initiative in 2021, which will contribute to market growth going forwards.


    • Scope
    • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Australia
    • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
    • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
    • Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts
    Reasons to Buy
    • What was the size of the Australia pharmaceuticals market by value in 2020?
    • What will be the size of the Australia pharmaceuticals market in 2025?
    • What factors are affecting the strength of competition in the Australia pharmaceuticals market?
    • How has the market performed over the last five years?
    • What are the main segments that make up Australia's pharmaceuticals market?


    1 Executive Summary
    1.1. Market value
    1.2. Market value forecast
    1.3. Geography segmentation
    1.4. Market share
    1.5. Market rivalry
    1.6. Competitive Landscape
    2 Market Overview
    2.1. Market definition
    2.2. Market analysis
    3 Market Data
    3.1. Market value
    4 Market Segmentation
    4.1. Geography segmentation
    5 Market Outlook
    5.1. Market value forecast
    6 Five Forces Analysis
    6.1. Summary
    6.2. Buyer power
    6.3. Supplier power
    6.4. New entrants
    6.5. Threat of substitutes
    6.6. Degree of rivalry
    7 Competitive Landscape
    7.1. Market share
    7.2. Who are the leading players?
    7.3. What are the strengths and weaknesses of leading players?
    7.4. What strategies do leading players follow?
    8 Company Profiles
    8.1. Pfizer Inc.
    8.2. Aspen Pharmacare Holdings Ltd
    8.3. AstraZeneca PLC
    8.4. GlaxoSmithKline Plc
    9 Macroeconomic Indicators
    9.1. Country data
    10 Appendix
    10.1. Methodology
    10.2. Industry associations
    10.3. Related MarketLine research
    10.4. About MarketLine
    List of Tables
    Table 1: Australia pharmaceuticals market value: $ billion, 2016-20
    Table 2: Australia pharmaceuticals market geography segmentation: $ billion, 2020
    Table 3: Australia pharmaceuticals market value forecast: $ billion, 2020-25
    Table 4: Australia pharmaceuticals market share: % share, by value, 2020
    Table 5: Pfizer Inc.: key facts
    Table 6: Pfizer Inc.: Annual Financial Ratios
    Table 7: Pfizer Inc.: Key Employees
    Table 8: Pfizer Inc.: Key Employees Continued
    Table 9: Aspen Pharmacare Holdings Ltd: key facts
    Table 10: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
    Table 11: Aspen Pharmacare Holdings Ltd: Key Employees
    Table 12: AstraZeneca PLC: key facts
    Table 13: AstraZeneca PLC: Annual Financial Ratios
    Table 14: AstraZeneca PLC: Key Employees
    Table 15: GlaxoSmithKline Plc: key facts
    Table 16: GlaxoSmithKline Plc: Annual Financial Ratios
    Table 17: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
    Table 18: GlaxoSmithKline Plc: Key Employees
    Table 19: GlaxoSmithKline Plc: Key Employees Continued
    Table 20: Australia size of population (million), 2016-20
    Table 21: Australia gdp (constant 2005 prices, $ billion), 2016-20
    Table 22: Australia gdp (current prices, $ billion), 2016-20
    Table 23: Australia inflation, 2016-20
    Table 24: Australia consumer price index (absolute), 2016-20
    Table 25: Australia exchange rate, 2016-20
    List of Figures
    Figure 1: Australia pharmaceuticals market value: $ billion, 2016-20
    Figure 2: Australia pharmaceuticals market geography segmentation: % share, by value, 2020
    Figure 3: Australia pharmaceuticals market value forecast: $ billion, 2020-25
    Figure 4: Forces driving competition in the pharmaceuticals market in Australia, 2020
    Figure 5: Drivers of buyer power in the pharmaceuticals market in Australia, 2020
    Figure 6: Drivers of supplier power in the pharmaceuticals market in Australia, 2020
    Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2020
    Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2020
    Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2020
    Figure 10: Australia pharmaceuticals market share: % share, by value, 2020

    $350
    $1,050

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings